Cargando…
Pharmacological manipulation of cyclic GMP levels in brain restores learning ability in animal models of hepatic encephalopathy: therapeutic implications
Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome present in patients with liver disease that includes impaired intellectual function. To develop therapeutic treatments to restore cognitive function, it is important to understand the molecular mechanisms that impair cognitive functi...
Autores principales: | Rodrigo, Regina, Monfort, Pilar, Cauli, Omar, Erceg, Slaven, Felipo, Vicente |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671733/ https://www.ncbi.nlm.nih.gov/pubmed/19412446 |
Ejemplares similares
-
Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase and cGMP-degrading phosphodiesterase, alterations in hyperammonemia
por: Monfort, Pilar, et al.
Publicado: (2005) -
cGMP modulates stem cells differentiation to neurons in brain in vivo pathological implications
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2011) -
Metabolism of cyclic GMP in non-alcoholic fatty liver disease in morbid obesity
por: Urios, Amparo, et al.
Publicado: (2011) -
Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology
por: Petraina, Alexandra, et al.
Publicado: (2021) -
Extracellular Cyclic GMP Modulates Membrane Expression of The GluA1 and GluA2 Subunits of AMPA Receptor in Cerebellum: Molecular Mechanisms Involved
por: Cabrera-Pastor, Andrea, et al.
Publicado: (2017)